It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Image source: Getty Images
CSL Limited (ASX: CSL)
According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $354.00 price target on this biotherapeutics giant's shares. This follows the release of an update from rival Takeda, which appears to indicate that the immunoglobulins market is strengthening. As a result, the broker believes that the key CSL Behring business is well-placed to deliver strong top line growth in FY 2023. The CSL share price is trading at $312.71 on Friday.
James Hardie Industries plc (ASX: JHX)
Analysts at Goldman Sachs have initiated coverage on this building products company's shares with a buy rating and $40.50 price target. While Goldman notes that near-term risks remain skewed to the downside, it believes the market has already priced in a trough in James Hardie's earnings in FY 2024. Its analysts feel that this provides cyclical upside to the current share price. The James Hardie share price is fetching $34.56 today.
Megaport Ltd (ASX: MP1)
A note out of Morgans reveals that its analysts have retained their add rating on this network as a service company's shares with a trimmed price target of $8.25. While Morgans acknowledges that it is difficult to know if the current declining sales momentum will persist, it appears optimistic it will only be a short term thing. In light of this, it sees value in Megaport's shares for those with a higher risk profile. The Megaport share price is trading at $5.99 this afternoon.
